Vimarsana
Biggest News Aggregation in the World

Page 48 - Ioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ioscience Today - Breaking & Trending Today

Renaissance BioScience - RNAi technology from bioengineered yeast - Vimarsana News

Renaissance BioScience - RNAi technology from bioengineered yeast

Renaissance BioScience is a private bioengineering company developing proprietary yeast strains for use in the food and beverage, healthcare and agriculture industries. It has been successful in commercially

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty - Vimarsana News

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty

LUND, Sweden, Jan. 19, 2022 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced the initiation a sponsored research collaboration to study biomarker data from Alligator's

Sixfold Bioscience Ltd: Sixfold Bioscience Joins Wellcome Leap R3 Funded Program to Boost RNA Readiness and Response - Vimarsana News

Sixfold Bioscience Ltd: Sixfold Bioscience Joins Wellcome Leap R3 Funded Program to Boost RNA Readiness and Response

LONDON, Jan. 19, 2022 /PRNewswire/ -- Sixfold Bioscience, the RNA Architects, today announced their selection for the Wellcome Leap R3: RNA Readiness + Response Program. Co-funded with

Alligator Bioscience Announces OPTIMIZE-1 Trial Update: Cohort Fully Dosed with No Adverse Effects Reported - Vimarsana News

Alligator Bioscience Announces OPTIMIZE-1 Trial Update: Cohort Fully Dosed with No Adverse Effects Reported

LUND, Sweden, Jan. 18, 2022 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced an update on the on-going OPTIMIZE-1 clinical Phase Ib/II trial with the company's

Lexaria Bioscience Corp.: Lexaria Comments on Study Examining Cannabinoids and SARS-CoV-2 - Vimarsana News

Lexaria Bioscience Corp.: Lexaria Comments on Study Examining Cannabinoids and SARS-CoV-2

"Cannabinoids have the potential to prevent as well as treat infection by SARS-CoV-2"KELOWNA, BC / ACCESSWIRE / January 18, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or